Compare Cadila Healthcare with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs ABBOTT INDIA - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE ABBOTT INDIA CADILA HEALTHCARE/
ABBOTT INDIA
 
P/E (TTM) x 14.8 44.7 33.2% View Chart
P/BV x 2.9 12.8 22.6% View Chart
Dividend Yield % 1.4 0.5 262.6%  

Financials

 CADILA HEALTHCARE   ABBOTT INDIA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
ABBOTT INDIA
Mar-18
CADILA HEALTHCARE/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs5586,110 9.1%   
Low Rs3623,996 9.0%   
Sales per share (Unadj.) Rs116.31,552.2 7.5%  
Earnings per share (Unadj.) Rs17.9188.8 9.5%  
Cash flow per share (Unadj.) Rs23.1196.4 11.8%  
Dividends per share (Unadj.) Rs3.5055.00 6.4%  
Dividend yield (eoy) %0.81.1 69.9%  
Book value per share (Unadj.) Rs85.4796.6 10.7%  
Shares outstanding (eoy) m1,023.7421.25 4,817.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.03.3 121.4%   
Avg P/E ratio x25.726.8 96.1%  
P/CF ratio (eoy) x19.925.7 77.3%  
Price / Book Value ratio x5.46.3 84.9%  
Dividend payout %19.629.1 67.2%   
Avg Mkt Cap Rs m470,664107,376 438.3%   
No. of employees `00011.83.3 355.8%   
Total wages/salary Rs m18,5453,937 471.1%   
Avg. sales/employee Rs Th10,072.79,929.3 101.4%   
Avg. wages/employee Rs Th1,569.11,185.1 132.4%   
Avg. net profit/employee Rs Th1,547.71,207.7 128.1%   
INCOME DATA
Net Sales Rs m119,04932,985 360.9%  
Other income Rs m1,1321,170 96.8%   
Total revenues Rs m120,18134,155 351.9%   
Gross profit Rs m28,4755,245 542.9%  
Depreciation Rs m5,388162 3,328.0%   
Interest Rs m91138 2,384.8%   
Profit before tax Rs m23,3086,215 375.0%   
Minority Interest Rs m6280-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,6442,203 256.2%   
Profit after tax Rs m18,2924,012 455.9%  
Gross profit margin %23.915.9 150.4%  
Effective tax rate %24.235.4 68.3%   
Net profit margin %15.412.2 126.3%  
BALANCE SHEET DATA
Current assets Rs m82,00522,655 362.0%   
Current liabilities Rs m60,7206,681 908.9%   
Net working cap to sales %17.948.4 36.9%  
Current ratio x1.43.4 39.8%  
Inventory Days Days7365 112.9%  
Debtors Days Days9829 337.2%  
Net fixed assets Rs m83,703835 10,018.7%   
Share capital Rs m1,024213 481.9%   
"Free" reserves Rs m86,42116,715 517.0%   
Net worth Rs m87,44516,928 516.6%   
Long term debt Rs m25,5510-   
Total assets Rs m180,65324,162 747.7%  
Interest coverage x26.6163.7 16.2%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.71.4 48.3%   
Return on assets %10.616.8 63.4%  
Return on equity %20.923.7 88.3%  
Return on capital %22.036.9 59.5%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m42,683369 11,581.6%   
Fx outflow Rs m11,2423,807 295.3%   
Net fx Rs m31,441-3,438 -914.5%   
CASH FLOW
From Operations Rs m9,1931,527 602.0%  
From Investments Rs m-9,737-2,148 453.2%  
From Financial Activity Rs m515-1,024 -50.3%  
Net Cashflow Rs m-29-1,646 1.8%  

Share Holding

Indian Promoters % 74.8 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 8.3 7.9 105.1%  
FIIs % 5.9 0.1 5,900.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 17.1 64.3%  
Shareholders   44,069 18,270 241.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   AJANTA PHARMA  FDC LTD.  SUN PHARMA  FRESENIUS KABI ONCO.  TTK HEALTHCARE  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Sep 20, 2019 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS